Flurpiridaz f-18 - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for flurpiridaz f-18 and what is the scope of patent protection?
Flurpiridaz f-18
is the generic ingredient in one branded drug marketed by Ge Hlthcare and is included in one NDA. Additional information is available in the individual branded drug profile pages.Summary for flurpiridaz f-18
| US Patents: | 0 |
| Tradenames: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Clinical Trials: | 4 |
| Patent Applications: | 60 |
| DailyMed Link: | flurpiridaz f-18 at DailyMed |
Recent Clinical Trials for flurpiridaz f-18
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| GE Healthcare | Phase 2 |
| GE Healthcare | Phase 3 |
| Pharmaceutical Product Development, LLC | Phase 3 |
US Patents and Regulatory Information for flurpiridaz f-18
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ge Hlthcare | FLYRCADO | flurpiridaz f-18 | SOLUTION;INTRAVENOUS | 215168-001 | Sep 27, 2024 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
